Logo - springer
Slogan - springer

Medicine - Internal Medicine | Current Hematologic Malignancy Reports - incl. option to publish open access (Editorial Board)

Current Hematologic Malignancy Reports

Current Hematologic Malignancy Reports

Editor-in-Chief: Ruben A. Mesa

ISSN: 1558-8211 (print version)
ISSN: 1558-822X (electronic version)

Journal no. 11899

80,33 € Personal Rate e-only
Get Subscription

Online subscription, valid from January through December of current calendar year

Immediate access to this year's issues via SpringerLink

1 Volume(-s) with 6 issue(-s) per annual subscription

Automatic annual renewal

More information: >> FAQs // >> Policy

Ruben A. Mesa (UT Health San Antonio Cancer Center, San Antonio, Texas, USA)

Editorial Board:

Frederick R. Appelbaum (Fred Hutchinson Cancer Research Center, Seattle, Washington, USA)
Michele Baccarani (University of Bologna, Bologna, Italy)
John C. Byrd (Ohio State University, Columbus, Ohio, USA)
Myron S. Czuczman (Roswell Park Cancer Institute, Buffalo, New York, USA)
David Gomez-Almaguer (Hospital Universitario UANL, Monterrey, Mexico)
Nelson Hamerschlack (Hospital Israelita Albert Einstein, Sao Paulo, Brazil)
Jean-Luc Harousseau (University Hospital Hotel Dieu, Nantes, France)

Claire Harrison (Guy's and St. Thomas' NHS Foundation Trust, London, England, United Kingdom)
Armand Keating (Princess Margaret Hospital, Ontario Cancer Institute, Toronto, Ontario, Canada)
Alan F. List (H. Lee Moffitt Cancer Center, Tampa, Florida, USA)

Jesús San Miguel (Hospital Universitario de Salamanca, Salamanca, Spain)
Emili Montserrat (University of Barcelona, Barcelona, Spain)
Carolina Pavlovsky (Angelica Ocampo Hospitalization and Clinical Research Center, Buenos Aires, Argentina)
Ching-Hon Pui (St. Jude Children’s Research Hospital, Memphis, Tennessee, USA)
John F. Seymour (Peter MacCallum Cancer Centre, Melbourne, Australia)
Koen Van Besien (University of Chicago, Chicago, Illinois, USA)

Sections and Section Editors:

Stem Cell Transplantation

Richard Maziarz (Oregon Health &Science University, Portland, Oregon, USA)

Chronic Lymphocytic Leukemias

Nitin Jain (University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA)

Acute  Lymphocytic Leukemias
Karen Ballen (Massachusetts General Hospital, Boston, Massachusetts, USA)

Acute Myeloid Leukemias

Harry Erba (University of Alabama at Birmingham, Birmingham, Alabama, USA)

Chronic Myeloid Leukemias

Javier Pinilla-Ibarz (H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, USA)

B-cell NHL, T-cell NHL, and Hodgkin Lymphoma

Daniel Persky (The University of Arizona Cancer Center, Tucson, Arizona, USA)

Health Economics

Nandita Khera (Mayo Clinic, Phoenix, Arizona, USA)

Myelodysplastic Syndromes

Michael Savona (Vanderbilt University School of Medicine, Nashville, Tennessee, USA)

Multiple Myeloma 
Prashant Kapoor (Mayo Clinic, Rochester, Minnesota, USA)

Myeloproliferative Disorders
Brady Stein (Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA)

CART and Immunotherapy

Marco Ruella (University of Pennsylvania, Philadelphia, Pennsylvania, USA)

Social Media Impact of Hematologic Malignancies

Naveen Pemmaraju (MD Anderson Cancer Center, Houston, Texas, USA)


Read this Journal on Springerlink

For authors and editors

  • Journal Citation Reports®
    2017 Impact Factor
  • 2.388
  • Aims and Scope

    Aims and Scope


    This journal intends to provide clear, insightful, balanced contributions by international experts that review the most important, recently published clinical findings related to the diagnosis, treatment, management, and prevention of hematologic malignancy.

    We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas, such as leukemia, lymphoma, myeloma, and T-cell and other lymphoproliferative malignancies. Section Editors, in turn, select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. An international Editorial Board reviews the annual table of contents, suggests articles of special interest to their country/region, and ensures that topics are current and include emerging research. Commentaries from well-known figures in the field are also provided.

  • Open Choice - Your Way to Open Access
  • Instructions for Authors

    Instructions for Authors


  • Conflict Of Interest Form (pdf, 613 kB)
  • Compliance with Ethical Requirements

    Compliance with Ethical Requirements


  • Author Academy: Training for Authors
  • Copyright Information

    Copyright Information


    Copyright Information

    For Authors

    Submission of a manuscript implies: that the work described has not been published before (except in form of an abstract or as part of a published lecture, review or thesis); that it is not under consideration for publication elsewhere; that its publication has been approved by all co-authors, if any, as well as – tacitly or explicitly – by the responsible authorities at the institution where the work was carried out.

    Author warrants (i) that he/she is the sole owner or has been authorized by any additional copyright owner to assign the right, (ii) that the article does not infringe any third party rights and no license from or payments to a third party is required to publish the article and (iii) that the article has not been previously published or licensed. The author signs for and accepts responsibility for releasing this material on behalf of any and all co-authors. Transfer of copyright to Springer (respective to owner if other than Springer) becomes effective if and when a Copyright Transfer Statement is signed or transferred electronically by the corresponding author. After submission of the Copyright Transfer Statement signed by the corresponding author, changes of authorship or in the order of the authors listed will not be accepted by Springer.

    The copyright to this article, including any graphic elements therein (e.g. illustrations, charts, moving images), is assigned for good and valuable consideration to Springer effective if and when the article is accepted for publication and to the extent assignable if assignability is restricted for by applicable law or regulations (e.g. for U.S. government or crown employees).

    The copyright assignment includes without limitation the exclusive, assignable and sublicensable right, unlimited in time and territory, to reproduce, publish, distribute, transmit, make available and store the article, including abstracts thereof, in all forms of media of expression now known or developed in the future, including pre- and reprints, translations, photographic reproductions and microform. Springer may use the article in whole or in part in electronic form, such as use in databases or data networks for display, print or download to stationary or portable devices. This includes interactive and multimedia use and the right to alter the article to the extent necessary for such use.

    Authors may self-archive the Author's accepted manuscript of their articles on their own websites. Authors may also deposit this version of the article in any repository, provided it is only made publicly available 12 months after official publication or later. He/she may not use the publisher's version (the final article), which is posted on SpringerLink and other Springer websites, for the purpose of self-archiving or deposit. Furthermore, the Author may only post his/her version provided acknowledgement is given to the original source of publication and a link is inserted to the published article on Springer's website. The link must be accompanied by the following text: "The final publication is available at link.springer.com".

    Prior versions of the article published on non-commercial pre-print servers like arXiv.org can remain on these servers and/or can be updated with Author's accepted version. The final published version (in pdf or html/xml format) cannot be used for this purpose. Acknowledgement needs to be given to the final publication and a link must be inserted to the published article on Springer's website, accompanied by the text "The final publication is available at link.springer.com". Author retains the right to use his/her article for his/her further scientific career by including the final published journal article in other publications such as dissertations and postdoctoral qualifications provided acknowledgement is given to the original source of publication.

    Author is requested to use the appropriate DOI for the article. Articles disseminated via link.springer.com are indexed, abstracted and referenced by many abstracting and information services, bibliographic networks, subscription agencies, library networks, and consortia.

    For Readers

    While the advice and information in this journal is believed to be true and accurate at the date of its publication, neither the authors, the editors, nor the publisher can accept any legal responsibility for any errors or omissions that may have been made. The publisher makes no warranty, express or implied, with respect to the material contained herein.

    All articles published in this journal are protected by copyright, which covers the exclusive rights to reproduce and distribute the article (e.g., as offprints), as well as all translation rights. No material published in this journal may be reproduced photographically or stored on microfilm, in electronic data bases, video disks, etc., without first obtaining written permission from the publisher (respective the copyright owner if other than Springer). The use of general descriptive names, trade names, trademarks, etc., in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.

    Springer has partnered with Copyright Clearance Center's RightsLink service to offer a variety of options for reusing Springer content. For permission to reuse our content please locate the material that you wish to use on link.springer.com or on springerimages.com and click on the permissions link or go to copyright.com, then enter the title of the publication that you wish to use. For assistance in placing a permission request, Copyright Clearance Center can be connected directly via phone: +1-855-239-3415, fax: +1-978-646-8600, or e-mail: info@copyright.com.

    © Springer Science+Business Media New York

Alerts for this journal


Get the table of contents of every new issue published in Current Hematologic Malignancy Reports.

Additional information